Loading...
Market
What will be the changes in Alchem International's executive team by end of 2024?
5
Resolution / Starting Odds
CEO resignation • 33%
Other executive resignation • 33%
No changes • 33%
Official company announcements and press releases
Story
EU Regulators Accuse Indian Drugmaker Alchem of Price-Fixing in Pharmaceutical Cartel
Jun 13, 2024, 09:49 AM
EU antitrust regulators have issued a formal statement of objections to Alchem International on Thursday, accusing the Indian drugmaker of participating in a pharmaceutical cartel to fix prices of a key ingredient used in drugs for stomach complaints. The allegations suggest that Alchem conspired with its rivals to manipulate the market for this essential component, leading to potentially higher costs for consumers. The formal complaint marks a significant step in the EU's ongoing efforts to combat anti-competitive practices in the pharmaceutical industry.
View original story
Similar markets
No changes • 25%
CEO change • 25%
CFO change • 25%
Both CEO and CFO change • 25%
Hiring of new executives • 25%
Internal promotions • 25%
No changes • 25%
Additional executive departures • 25%
CEO replaced • 25%
CFO replaced • 25%
Other executives replaced • 25%
No change in leadership • 25%
No change in executive team • 33%
Change in CFO or other financial executives • 33%
Change in CEO • 34%
Major reshuffle in senior management • 33%
Stability with no significant changes • 33%
Appointment of external executives • 33%
CEO remains • 33%
New CEO • 33%
CEO and other top executives replaced • 33%
CEO resigns • 33%
Other senior executives resign • 33%
No leadership changes • 33%
No change • 25%
CEO changes • 25%
CFO changes • 25%
Other executive changes • 25%
CEO steps down • 33%
New Chief Legal Officer appointed • 33%
No major executive changes • 34%
No change in leadership • 34%
New CEO appointed • 33%
Major overhaul of executive team • 33%
CEO Change • 25%
CFO Change • 25%
CTO Change • 25%
No Change • 25%
